Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

P. Kenemans; N.J. Bundred; J.M. Foidart; E. Kubista; B. von Schoultz; P. Sismondi; R. Vassilopoulou-Sellin; C.H. Yip; J. Egberts; M. Mol-Arts; R. Mulder; S. van Os; M.W. Beckman; P.J. van Diest; L.J. Kappelle; X et al.; Group LIBERATE Study

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

Translated title of the contribution: Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

P. Kenemans, N.J. Bundred, J.M. Foidart, E. Kubista, B. von Schoultz, P. Sismondi, R. Vassilopoulou-Sellin, C.H. Yip, J. Egberts, M. Mol-Arts, R. Mulder, S. van Os, M.W. Beckman, P.J. van Diest, L.J. Kappelle, X et al., Group LIBERATE Study

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
Original language	Undefined/Unknown
Pages (from-to)	135-146
Number of pages	12
Journal	LANCET ONCOLOGY
Volume	10
Issue number	2
Publication status	Published - 2009

Cite this

Kenemans, P., Bundred, N. J., Foidart, J. M., Kubista, E., von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C. H., Egberts, J., Mol-Arts, M., Mulder, R., van Os, S., Beckman, M. W., van Diest, P. J., Kappelle, L. J., et al., X., & LIBERATE Study, G. (2009). Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. LANCET ONCOLOGY, 10(2), 135-146.

@article{65a8c0e3056144828136023d985a211b,

title = "Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial",

author = "P. Kenemans and N.J. Bundred and J.M. Foidart and E. Kubista and {von Schoultz}, B. and P. Sismondi and R. Vassilopoulou-Sellin and C.H. Yip and J. Egberts and M. Mol-Arts and R. Mulder and {van Os}, S. and M.W. Beckman and {van Diest}, P.J. and L.J. Kappelle and {et al.}, X and {LIBERATE Study}, Group",

year = "2009",

language = "Undefined/Unknown",

volume = "10",

pages = "135--146",

journal = "LANCET ONCOLOGY",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "2",

}

Kenemans, P, Bundred, NJ, Foidart, JM, Kubista, E, von Schoultz, B, Sismondi, P, Vassilopoulou-Sellin, R, Yip, CH, Egberts, J, Mol-Arts, M, Mulder, R, van Os, S, Beckman, MW, van Diest, PJ , Kappelle, LJ, et al., X & LIBERATE Study, G 2009, 'Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial', LANCET ONCOLOGY, vol. 10, no. 2, pp. 135-146.

TY - JOUR

T1 - Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

AU - Kenemans, P.

AU - Bundred, N.J.

AU - Foidart, J.M.

AU - Kubista, E.

AU - von Schoultz, B.

AU - Sismondi, P.

AU - Vassilopoulou-Sellin, R.

AU - Yip, C.H.

AU - Egberts, J.

AU - Mol-Arts, M.

AU - Mulder, R.

AU - van Os, S.

AU - Beckman, M.W.

AU - van Diest, P.J.

AU - Kappelle, L.J.

AU - et al., X

AU - LIBERATE Study, Group

PY - 2009

Y1 - 2009

M3 - Article

SN - 1470-2045

VL - 10

SP - 135

EP - 146

JO - LANCET ONCOLOGY

JF - LANCET ONCOLOGY

IS - 2

ER -